{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-036981","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2023-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.064632+00:00","generated_at":"2026-06-10T00:38:34.114528+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CMS expands carotid stenting coverage to asymptomatic/standard-risk patients; InspireMD supports","bullets":["CMS final NCD extends CAS coverage to asymptomatic and standard-risk patients, expanding addressable market.","InspireMD advancing CAS and TCAR programs in U.S. and E.U. using CGuard EPS stent system.","C-GUARDIANS IDE trial completed enrollment; 30-day safety results at VIVA Nov 1, 2023; PMA filing anticipated H2 2024.","CGuard EPS stent studied in nine clinical trials with >1,850 patients and over 40,000 real-world procedures.","CEO says CMS decision will accelerate shift from open surgery to endovascular 'stent first' approach."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-036981","json":"https://secwatch.observer/filing/0001493152-23-036981.json","markdown":"https://secwatch.observer/filing/0001493152-23-036981.md","text":"https://secwatch.observer/filing/0001493152-23-036981.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223036981/0001493152-23-036981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315223036981/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:38:34.114528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}